Similar medications and substitutes for LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN
In short: Pluvicto (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) belongs to the Radioligand Therapeutic Agent class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Pluvicto is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Pluvicto in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.